Clifford Henderson, MD
Dermatology · Oklahoma City, OKNPI 1477713642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 485 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations.
Across 485 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Lilly USA, LLC$866
- Johnson & Johnson$786
- Sanofi$605
- plus $3K from 29 others
Across 3 payments — averaging $12,073 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$36K
What the payments were for
- Food & beverage$8,943100%
- Education$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,245 |
| Novartis | 72 | $1,060 |
| Regeneron Healthcare Solutions, Inc. | 39 | $1,006 |
| Lilly USA, LLC | 52 | $866 |
| Johnson & Johnson | 49 | $786 |
| Sanofi | 30 | $605 |
| LEO Pharma Inc. | 29 | $521 |
| Pfizer | 20 | $453 |
| Amgen | 14 | $340 |
| E.r. Squibb & Sons, L.L.C. | 16 | $279 |
| Organogenesis Inc. | 9 | $223 |
| Incyte Corporation | 12 | $210 |
| Sun Pharmaceutical Industries Inc. | 9 | $184 |
| Dermavant Sciences, Inc. | 10 | $150 |
| UCB, Inc. | 7 | $149 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $148 |
| Dermira, Inc. | 1 | $122 |
| Mayne Pharma Commercial LLC | 4 | $79 |
| Galderma Laboratories, L.p. | 5 | $75 |
| VYNE Pharmaceuticals Inc. | 4 | $64 |
| Arcutis Biotherapeutics, Inc. | 4 | $59 |
| Botanix SB Inc | 2 | $41 |
| Genentech USA, Inc. | 3 | $41 |
| Bristol Myers Squibb | 2 | $37 |
| Aclaris Therapeutics, Inc. | 2 | $31 |
| Kyowa Kirin, Inc. | 2 | $29 |
| Boehringer Ingelheim | 2 | $27 |
| Organon | 2 | $24 |
| Celltrion USA Inc. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Biofrontera Inc. | 1 | $16 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QBREXZA$122
How this compares
$8,979 in reported general payments places this provider in the 75th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 831 | $6,779 |
| Cephalexin | 643 | $2,715 |
| Doxycycline Hyclate | 146 | $1,421 |
| Fluconazole | 11 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $82 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $72 |
| Ciprofloxacin Hcl | 16 | $71 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
- Courtney CookOklahoma City$10K
- Roy RindlerOklahoma City$9K
- Emily ArchbaldOklahoma City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.